NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...
Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback